Omega-3 fatty acids

Generic Name: Omega-3 fatty acids

Brand Names: Animi-3 With Vitamin D, Vitafol-one

Drug Type: Small Molecule

Chemical Formula: -

CAS Number: 329042-31-1

Unique Ingredient Identifier: 71M78END5S

Background: Omega-3 fatty acids are polyunsaturated fatty acids (PUFAs) with a double bond at the third carbon atom from the end of the carbon chain. The three types of omega-3 fatty acids involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) (both commonly found in fish oil that origin...

Indication: Provided as daily supplements. Aa preparation of omega-3-acid ethyl esters is licensed in UK for prevention of recurrent events after myocardial infarction in addition to treatment of hypertriglyceridaemia.

Associated Conditions: -

Associated Therapies: Nutritional supplementation, Parenteral Nutrition

Clinical Trials

Septic Encephalopathy and Late Cognitive Dysfunction

Phase 4

Completed

Conditions: Sepsis
Severe Sepsis

Interventions: Drug: n-3 fatty acids

First Posted Date: 2008-10-15

Last Posted Date: 2015-03-10

Lead Sponsor: University Hospital, Basel, Switzerland

Target Recruit Count: 50

Registration Number: NCT00772096

Locations: 🇨🇭
University Hospital Basel, Basel, Switzerland

Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)

Not Applicable

Completed

Conditions: Posttraumatic Stress Disorder

Interventions: Drug: Placebo
Drug: Omega-3 Fatty Acid

First Posted Date: 2008-03-26

Last Posted Date: 2019-08-20

Lead Sponsor: Durham VA Medical Center

Target Recruit Count: 18

Registration Number: NCT00644423

Locations: 🇺🇸
Durham VA Medical Center, Durham, North Carolina, United States

Effects of Fish Oils on Inflammation and Insulin Resistance

Not Applicable

Completed

Conditions: Metabolic Syndrome
Insulin Resistance

Interventions: Drug: omega-3 fatty acid
Drug: placebo

First Posted Date: 2007-12-24

Last Posted Date: 2018-05-16

Lead Sponsor: Philip Kern

Target Recruit Count: 33

Registration Number: NCT00579436

Locations: 🇺🇸
University of Kentucky Medical Cener, Lexington, Kentucky, United States

Effect of Dietary Supplements With Fish Oil on Mannitol-induced Airway Sensitivity & Inflammation in Persons With Asthma

Phase 2

Completed

Conditions: Asthma

Interventions: Drug: omega-3 fatty acid

First Posted Date: 2007-09-10

Last Posted Date: 2012-03-16

Lead Sponsor: Firestone Institute for Respiratory Health

Target Recruit Count: 24

Registration Number: NCT00526357

Locations: 🇨🇦
Firestone Institute for Respiratory Health, Hamilton, Ontario, Canada

Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders

Not Applicable

Completed

Conditions: Autism

Interventions: Other: Placebo
Drug: Omega 3 fatty acids

First Posted Date: 2007-05-01

Last Posted Date: 2021-01-26

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 17

Registration Number: NCT00467818

Locations: 🇺🇸
University Behavioral Health Care Building, UMDNJ-RWJMS, Piscataway, New Jersey, United States

Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.

Phase 2

Conditions: Chronic Hepatitis C

First Posted Date: 2006-12-06

Last Posted Date: 2006-12-06

Lead Sponsor: Bnai Zion Medical Center

Target Recruit Count: 60

Registration Number: NCT00408304

Locations: 🇮🇱
Bnai Zion Medical Center, Haifa, Israel

Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis

Phase 4

Completed

Conditions: Schizophrenia
Prodrome

Interventions: Drug: Omega 3 fatty acids

First Posted Date: 2006-11-07

Last Posted Date: 2007-12-27

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 81

Registration Number: NCT00396643

Locations: 🇦🇹
Medical University of Vienna, Department of Child and Adolescent Psychiatry, Vienna, Austria

Omega-3 Fatty Acids in Adolescent Depression

Phase 2

Completed

Conditions: Adolescent Depression

Interventions: Drug: Omega-3 Fatty Acids
Drug: corn oil

First Posted Date: 2006-04-11

Last Posted Date: 2018-04-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 57

Registration Number: NCT00312897

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression

Phase 2

Conditions: Major Depression

First Posted Date: 2006-02-09

Last Posted Date: 2006-09-13

Lead Sponsor: The University of New South Wales

Target Recruit Count: 52

Registration Number: NCT00289484

Locations: 🇦🇺
The University of New South Wales/Black Dog Institute, Sydney, New South Wales, Australia

A Study of Omega-3 as a Treatment for Major Depression

Phase 2

Conditions: Dysthymia
Major Depression

First Posted Date: 2005-10-13

Last Posted Date: 2006-09-13

Lead Sponsor: The University of New South Wales

Target Recruit Count: 128

Registration Number: NCT00238758

Locations: 🇦🇺
The University of New South Wales/ Black Dog Institute, Sydney, New South Wales, Australia

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy